Imsidolimab (ANB 019) is a high-affinity humanized monoclonal antibody that targets IL-36 receptor (IL-36R), effectively antagonizing IL-36 cytokine signal transduction. This antibody is designed for potential therapeutic use in managing generalized pustular psoriasis (GPP) and various other inflammatory skin conditions. Its specificity for IL-36R makes it a valuable tool for research and treatment development in dermatological inflammation.
Imsidolimab (ANB 019) is a high-affinity humanized monoclonal antibody that targets IL-36 receptor (IL-36R), effectively antagonizing IL-36 cytokine signal transduction. This antibody is designed for potential therapeutic use in managing generalized pustular psoriasis (GPP) and various other inflammatory skin conditions. Its specificity for IL-36R makes it a valuable tool for research and treatment development in dermatological inflammation.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
